Script section containing code for Liveperson Chat Solution

Hoover's - A D&B Company - We Make It Easier
Buy Reports For This Company

Crucell N.V.
Leiden The Netherlands
  (NASDAQ: CRXL)

btn-overview-2btn-people-1btn-competition-1btn-financials-1

Company Description

Crucell wants to play a crucial role in the fight against deadly diseases. The global biotech firm develops, produces, and markets vaccines and antibodies to prevent and treat infectious diseases. Many of its products are based on its PER.C6 technology platform, and its primary product lines are focused on pediatric, travel, endemic (native to certain regions), and respiratory ailments. Crucell's marketed vaccines fight about a dozen major infectious diseases (including diptheria, hepatitis A and B, influenza, and typhoid) and are offered in more than 100 countries worldwide. The company was acquired by Johnson & Johnson (J&J) in 2011, becoming J&J's primary vaccine unit.

Archimedesweg 4-6Phone: +31-71-519-91-01
Leiden 2333 CNFax: +31-71-519-98-00Map Map This Company
The Netherlands

Try a Full Premium Subscription

Access over 85 million companies
Call (866) 443-3939 or

btn-free-trial

Prepare for your Sales call

Try a Small Business Subscription
Starting $89 per month

btn-subscribe-now

Crucell N.V. Rankings

Executives

18 executives listed for Crucell N.V.'s Leiden, The Netherlands location.
ChairmanJan OosterveldE-mail
President and CEORonald BrusE-mail
COOCees de JongE-mail

More Crucell N.V. Executives

Financials

Company TypeSubsidiary - NASDAQ: CRXL Headquarters
Fiscal Year-EndDecember
2010 Employees1,300
More Crucell N.V. Financials
D&B logoDNBi

Leverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Crucell N.V. now.

  • Reduce risk.
  • Drive greater profitability.
  • Increase cash flow.
Get a Credit Report Now

Sponsored Links